Neuroinflammation in Parkinson's disease: a target for neuroprotection?, The Lancet Neurology, vol.8, issue.4, pp.382-397, 2009. ,
DOI : 10.1016/S1474-4422(09)70062-6
Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease, Nat Med, vol.5, pp.1403-1409, 1999. ,
NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease, Proceedings of the National Academy of Sciences, vol.100, issue.10, pp.6145-6150, 2003. ,
DOI : 10.1073/pnas.0937239100
MAC1 mediates LPS-induced production of superoxide by microglia: The role of pattern recognition receptors in dopaminergic neurotoxicity, Glia, vol.170, issue.13, pp.259-277, 2007. ,
DOI : 10.1002/glia.20545
Macrophage Antigen Complex-1 Mediates Reactive Microgliosis and Progressive Dopaminergic Neurodegeneration in the MPTP Model of Parkinson's Disease, The Journal of Immunology, vol.181, issue.10, pp.7194-7204, 2008. ,
DOI : 10.4049/jimmunol.181.10.7194
Cytokine-induced respiratory burst of human neutrophils: dependence on extracellular matrix proteins and CD11/CD18 integrins, The Journal of Cell Biology, vol.109, issue.3, pp.1341-1349, 1989. ,
DOI : 10.1083/jcb.109.3.1341
The Expanding Role for ITAM-Based Signaling Pathways in Immune Cells, Science's STKE, vol.2007, issue.377, p.2, 2007. ,
DOI : 10.1126/stke.3772007re2
Integrin signaling in neutrophils and macrophages uses adaptors containing immunoreceptor tyrosine-based activation motifs, Nature Immunology, vol.54, issue.12, pp.1326-1333, 2006. ,
DOI : 10.1074/jbc.M311618200
Developmental Neuronal Death in Hippocampus Requires the Microglial CD11b Integrin and DAP12 Immunoreceptor, Journal of Neuroscience, vol.28, issue.32, pp.8138-8143, 2008. ,
DOI : 10.1523/JNEUROSCI.1006-08.2008
Immunohistochemical characterization of microglia in Nasu-Hakola disease brains, Neuropathology, vol.105, issue.1, pp.363-375, 2011. ,
DOI : 10.1111/j.1440-1789.2010.01174.x
Impaired Synaptic Function in the Microglial KARAP/DAP12-Deficient Mouse, Journal of Neuroscience, vol.24, issue.50, pp.11421-11428, 2004. ,
DOI : 10.1523/JNEUROSCI.2251-04.2004
Combined Natural Killer Cell and Dendritic Cell Functional Deficiency in KARAP/DAP12 Loss-of-Function Mutant Mice, Immunity, vol.13, issue.3, pp.355-364, 2000. ,
DOI : 10.1016/S1074-7613(00)00035-2
Paraxanthine, the Primary Metabolite of Caffeine, Provides Protection against Dopaminergic Cell Death via Stimulation of Ryanodine Receptor Channels, Molecular Pharmacology, vol.74, issue.4, pp.980-989, 2008. ,
DOI : 10.1124/mol.108.048207
Cytotoxic Effect of Brain Macrophages on Developing Neurons, European Journal of Neuroscience, vol.174, issue.11, pp.1155-1164, 1991. ,
DOI : 10.1016/0006-8993(89)91550-3
Quantification of mRNA using real-time RT-PCR, Nature Protocols, vol.113, issue.3, pp.1559-1582, 2006. ,
DOI : 10.1038/nprot.2006.236
Immune cell migration in inflammation: present and future therapeutic targets, Nature Immunology, vol.23, issue.12, pp.1182-1190, 2005. ,
DOI : 10.1038/ni1275
3-Hydroxymorphinan is neurotrophic to dopaminergic neurons and is also neuroprotective against LPS-induced neurotoxicity, The FASEB Journal, vol.19, pp.395-397, 2005. ,
DOI : 10.1096/fj.04-1586fje
Tyrosine Hydroxylase mRNA Expression by Dopaminergic Neurons in Culture: Effect of 1 -Methyl-4-Phenylpyridinium Treatment, Journal of Neurochemistry, vol.46, issue.2, pp.527-532, 1991. ,
DOI : 10.1016/0304-3940(86)90083-2
Superoxide production in rat hippocampal neurons: selective imaging with hydroethidine, J Neurosci, vol.16, pp.1324-1336, 1996. ,
Parkinson's Disease, Neuron, vol.39, issue.6, pp.889-909, 2003. ,
DOI : 10.1016/S0896-6273(03)00568-3
Microglia Promote the Death of Developing Purkinje Cells, Neuron, vol.41, issue.4, pp.535-547, 2004. ,
DOI : 10.1016/S0896-6273(04)00069-8
Phagocytosis in the developing CNS: more than clearing the corpses, Current Opinion in Neurobiology, vol.15, issue.1, pp.101-107, 2005. ,
DOI : 10.1016/j.conb.2005.01.006
Distribution and signaling of TREM2/DAP12, the receptor system mutated in human polycystic lipomembraneous osteodysplasia with sclerosing leukoencephalopathy dementia, European Journal of Neuroscience, vol.57, issue.10, pp.2617-2628, 2004. ,
DOI : 10.1016/S0920-1211(98)00038-2
Toll-like receptor 4: the missing link of the cerebral innate immune response triggered by circulating gram-negative bacterial cell wall components, The FASEB Journal, vol.15, issue.1, pp.155-163, 2001. ,
DOI : 10.1096/fj.00-0339com
Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists, Nature Medicine, vol.26, issue.5, pp.552-559, 2007. ,
DOI : 10.1038/nm1589
A Vicious Cycle Involving Release of Heat Shock Protein 60 from Injured Cells and Activation of Toll-Like Receptor 4 Mediates Neurodegeneration in the CNS, Journal of Neuroscience, vol.28, issue.10, pp.2320-2331, 2008. ,
DOI : 10.1523/JNEUROSCI.4760-07.2008
The surface-exposed chaperone, Hsp60, is an agonist of the microglial TREM2 receptor, Journal of Neurochemistry, vol.174, issue.1, pp.284-294, 2009. ,
DOI : 10.1111/j.1471-4159.2009.06130.x
Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12, Nature Immunology, vol.19, issue.6, pp.579-586, 2005. ,
DOI : 10.1016/S0022-1759(98)00204-X
Cutting Edge: Inhibition of TLR and FcR Responses in Macrophages by Triggering Receptor Expressed on Myeloid Cells (TREM)-2 and DAP12, The Journal of Immunology, vol.177, issue.4, pp.2051-2055, 2006. ,
DOI : 10.4049/jimmunol.177.4.2051